Related references
Note: Only part of the references are listed.The Macrocyclic Peptide Natural Product CJ-15,208 Is Orally Active and Prevents Reinstatement of Extinguished Cocaine-Seeking Behavior
Jane V. Aldrich et al.
JOURNAL OF NATURAL PRODUCTS (2013)
Discovery of Small Molecule Kappa Opioid Receptor Agonist and Antagonist Chemotypes through a HTS and Hit Refinement Strategy
Kevin J. Frankowski et al.
ACS CHEMICAL NEUROSCIENCE (2012)
Novel opioid cyclic tetrapeptides: Trp isomers of CJ-15,208 exhibit distinct opioid receptor agonism and short-acting κ opioid receptor antagonism
Nicolette C. Ross et al.
BRITISH JOURNAL OF PHARMACOLOGY (2012)
A Combination of Buprenorphine and Naltrexone Blocks Compulsive Cocaine Intake in Rodents Without Producing Dependence
Sunmee Wee et al.
SCIENCE TRANSLATIONAL MEDICINE (2012)
Long-acting κ opioid antagonists nor-BNI, GNTI and JDTic: pharmacokinetics in mice and lipophilicity
Thomas A Munro et al.
BMC Pharmacology & Toxicology (2012)
Quantitative PK–PD Model-Based Translational Pharmacology of a Novel Kappa Opioid Receptor Antagonist Between Rats and Humans
Cheng Chang et al.
AAPS Journal (2011)
Special Issue: Guide to Receptors and Channels, 5th Edition Abstracts
Stephen P. H. Alexander et al.
BRITISH JOURNAL OF PHARMACOLOGY (2011)
Polysorbates as novel lipid-modulating candidates for reducing serum total cholesterol and low-density lipoprotein levels in hyperlipidemic C57BL/6J mice and rats
Xiaorong Li et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2011)
Identification of short-acting κ-opioid receptor antagonists with anxiolytic-like activity
Matthew F. Peters et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2011)
Discovery of Aminobenzyloxyarylamides as κ Opioid Receptor Selective Antagonists: Application to Preclinical Development of a κ Opioid Receptor Antagonist Receptor Occupancy Tracer
Charles H. Mitch et al.
JOURNAL OF MEDICINAL CHEMISTRY (2011)
Duration of Action of a Broad Range of Selective κ-Opioid Receptor Antagonists Is Positively Correlated with c-Jun N-Terminal Kinase-1 Activation
Erica J. Melief et al.
MOLECULAR PHARMACOLOGY (2011)
Pharmacological Characterization of 2-Methyl-N-((2′-(pyrrolidin-1-ylsulfonyl)biphenyl-4-yl)methyl)propan-1-amine (PF-04455242), a High-Affinity Antagonist Selective for κ-Opioid Receptors
S. Grimwood et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2011)
Discovery of 8-azabicyclo[3.2.1]octan-3-yloxy-benzamides as selective antagonists of the kappa opioid receptor. Part 1
Todd A. Brugel et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2010)
Guidelines for reporting experiments involving animals: the ARRIVE guidelines
J. C. McGrath et al.
BRITISH JOURNAL OF PHARMACOLOGY (2010)
Animal research: Reporting in vivo experiments: The ARRIVE guidelines
Carol Kilkenny et al.
BRITISH JOURNAL OF PHARMACOLOGY (2010)
Synthetic therapeutic peptides: science and market
Patrick Vlieghe et al.
DRUG DISCOVERY TODAY (2010)
The effects of excipients on transporter mediated absorption
Jonathan Goole et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2010)
Analogues of (3R)-7-Hydroxy-N-[(1S)-1-{[(3R,4R)-4-(3-hydroxyphenyl)-3,4-dimethyl-1-piperidinyl]methyl}-2-methylpropyl)-1,2,3,4-tetrahydro-3-isoquinolinecarboxamide (JDTic). Synthesis and in Vitro and in Vivo Opioid Receptor Antagonist Activity
Scott P. Runyon et al.
JOURNAL OF MEDICINAL CHEMISTRY (2010)
Effectiveness of analogs of the kappa opioid receptor antagonist (3R)-7-Hydroxy-N-((1S)-1-{[(3R,4R)-4-(3-hydroxyphenyl)-3,4-dimethyl-1-piperidinyl]methyl}-2-methylpropyl)-1,2,3,4-tetrahydro-3-isoquinolinecarboxamide (JDTic) to reduce U50,488-induced diuresis and stress-induced cocaine reinstatement in rats
Patrick M. Beardsley et al.
PSYCHOPHARMACOLOGY (2010)
The role of the dynorphin-kappa opioid system in the reinforcing effects of drugs of abuse
Sunmee Wee et al.
PSYCHOPHARMACOLOGY (2010)
Effect of the selective kappa-opioid receptor antagonist JDTic on nicotine antinociception, reward, and withdrawal in the mouse
K. J. Jackson et al.
PSYCHOPHARMACOLOGY (2010)
Synthesis of CJ-15,208, a novel κ-opioid receptor antagonist
Nicolette C. Ross et al.
TETRAHEDRON LETTERS (2010)
Peptide Kappa Opioid Receptor Ligands: Potential for Drug Development
Jane V. Aldrich et al.
AAPS JOURNAL (2009)
Nascent structure-activity relationship study of a diastereomeric series of kappa opioid receptor antagonists derived from CJ-15,208
Roland E. Dolle et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2009)
Zyklophin, a systemically active selective kappa opioid receptor peptide antagonist with short duration of action
Jane V. Aldrich et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Inhibition of kappa opioid receptors attenuated increased cocaine intake in rats with extended access to cocaine
Sunmee Wee et al.
PSYCHOPHARMACOLOGY (2009)
Stress-induced reinstatement of cocaine seeking is mediated by the kappa opioid system
Van A. Redila et al.
PSYCHOPHARMACOLOGY (2008)
κ agonist-induced reinstatement of cocaine seeking in squirrel monkeys:: A role for opioid and stress-related mechanisms
Glenn R. Valdez et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2007)
Dynorphin and the pathophysiology of drug addiction
T. S. Shippenberg et al.
PHARMACOLOGY & THERAPEUTICS (2007)
Reinstatement of cocaine place-conditioning prevented by the peptide kappa-opioid receptor antagonist arodyn
A. N. Carey et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2007)
Conformational flexibility, internal hydrogen bonding, and passive membrane permeability: Successful in silico prediction of the relative permeabilities of cyclic peptides
Taha Rezai et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2006)
Naltrexone and buprenorphine combination in the treatment of opioid dependence
G. Gerra et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2006)
Prior activation of kappa opioid receptors by U50,488 mimics repeated forced swim stress to potentiate cocaine place preference conditioning
JP McLaughlin et al.
NEUROPSYCHOPHARMACOLOGY (2006)
Pharmacokinetics of the plant-derived κ-opioid hallucinogen salvinorin a in nonhuman primates
MD Schmidt et al.
SYNAPSE (2005)
Differential effects of the novel kappa opioid receptor antagonist, JDTic, on reinstatement of cocaine-seeking induced by footshock stressors vs cocaine primes and its antidepressant-like effects in rats
PM Beardsley et al.
PSYCHOPHARMACOLOGY (2005)
[Nα-BenzylTyr1,cyclo(D-Asp5,Dap8)]dynorphin A-(1-11)NH2 cyclized in the address domain is a novel K-opioid receptor antagonist
KA Patkar et al.
JOURNAL OF MEDICINAL CHEMISTRY (2005)
Altered extracellular striatal in vivo biotransformation of the opioid neuropeptide dynorphin A(1-17) in the unilateral 6-OHDA rat model of Parkinson's disease
R Klintenberg et al.
JOURNAL OF MASS SPECTROMETRY (2005)
Kappa opioid antagonists: Past successes and future prospects
MD Metcalf et al.
AAPS JOURNAL (2005)
Comparison of pharmacological activities of three distinct kappa ligands (salvinorin A, TRK-820 and 3FLB) on kappa opioid receptors in vitro and their antipruritic and antinociceptive activities in vivo
Y Wang et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2005)
Solubilizing excipients in oral and injectable formulations
RG Strickley
PHARMACEUTICAL RESEARCH (2004)
Prolonged kappa opioid receptor phosphorylation mediated by G-protein receptor kinase underlies sustained analgesic tolerance
JP McLaughlin et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Stress increases dynorphin immunoreactivity in limbic brain regions and dynorphin antagonism produces antidepressant-like effects
Y Shirayama et al.
JOURNAL OF NEUROCHEMISTRY (2004)
Effects of the kappa opioid agonist U50,488 and the kappa opioid antagonist nor-binaltorphimine on choice between cocaine and food in rhesus monkeys
SS Negus
PSYCHOPHARMACOLOGY (2004)
Pharmacological properties of JDTic:: a novel κ-opioid receptor antagonist
I Carroll et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2004)
Dynorphin A(1-17) biotransformation in striatum of freely moving rats using microdialysis and matrix-assisted laser desorption/ionization mass spectrometry
B Reed et al.
JOURNAL OF NEUROCHEMISTRY (2003)
CJ-15,208, a novel kappa opioid receptor antagonist from a fungus, Ctenomyces serratus ATCC15502
T Saito et al.
JOURNAL OF ANTIBIOTICS (2002)
An open-label study of a functional opioid κ antagonist in the treatment of opioid dependence
RB Rothman et al.
JOURNAL OF SUBSTANCE ABUSE TREATMENT (2000)
Share Paper
